Northern Trust
EWTX icon

Northern Trust’s Edgewise Therapeutics EWTX Stock Holding History

Northern Trust’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
671,270
+94,714
+16% +$3.27M ﹤0.01% 1613
2026
Q1 		$18.2M Buy
576,556
+16,907
+3% +$488K ﹤0.01% 1736
2025
Q4 		$13.9M Sell
559,649
-28,233
-5% -$567K ﹤0.01% 1910
2025
Q3 		$9.54M Sell
587,882
-15,016
-2% -$213K ﹤0.01% 2139
2025
Q2 		$7.9M Sell
602,898
-3,794
-0.6% -$54.7K ﹤0.01% 2204
2025
Q1 		$13.3M Sell
606,692
-4,614
-0.8% -$121K ﹤0.01% 1874
2024
Q4 		$16.3M Buy
611,306
+35,426
+6% +$1.13M ﹤0.01% 1827
2024
Q3 		$15.4M Buy
575,880
+67,189
+13% +$1.34M ﹤0.01% 1798
2024
Q2 		$9.16M Buy
508,691
+9,171
+2% +$160K ﹤0.01% 2045
2024
Q1 		$9.11M Buy
499,520
+136,277
+38% +$2.17M ﹤0.01% 2092
2023
Q4 		$3.97M Buy
363,243
+18,327
+5% +$129K ﹤0.01% 2637
2023
Q3 		$1.98M Buy
344,916
+5,459
+2% +$37.1K ﹤0.01% 2948
2023
Q2 		$2.63M Buy
339,457
+33,373
+11% +$281K ﹤0.01% 2851
2023
Q1 		$2.04M Sell
306,084
-10,748
-3% -$99.6K ﹤0.01% 2930
2022
Q4 		$2.83M Buy
316,832
+77,932
+33% +$731K ﹤0.01% 2810
2022
Q3 		$2.35M Buy
238,900
+21,633
+10% +$219K ﹤0.01% 2929
2022
Q2 		$1.73M Sell
217,267
-76,685
-26% -$580K ﹤0.01% 3132
2022
Q1 		$2.85M Sell
293,952
-8,238
-3% -$106K ﹤0.01% 2913
2021
Q4 		$4.62M Buy
302,190
+186,617
+161% +$3.36M ﹤0.01% 2730
2021
Q3 		$1.92M Sell
115,573
-11,156
-9% -$202K ﹤0.01% 3314
2021
Q2 		$2.7M Buy
+126,729
New +$3.46M ﹤0.01% 3212

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's EWTX Position: Q2 2026 in Review

Northern Trust increased its Edgewise Therapeutics (EWTX) stake by 16% in Q2 2026, buying an estimated $3.27M and bringing the position to 671,270 shares worth $27.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

Northern Trust first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Northern Trust held 671,270 shares of Edgewise Therapeutics worth $27.3M as of Q2 2026.
  • Northern Trust bought 94,714 Edgewise Therapeutics shares in Q2 2026, an estimated $3.27M.
  • Edgewise Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1613 holding.
  • Northern Trust first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.